NeurologyLive® Friday 5 — April 21, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 21, 2023.
This Week on NeurologyLive® — April 17, 2023
Here's some of what is coming soon to NeurologyLive® this week.
EASEE Device Reduces Seizures in DRE, Narcolepsy Incidence Increased During H1N1 Pandemic, Trial of GTX-104 Moving Forward
Neurology News Network for the week ending April 15, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — April 14, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 14, 2023.
This Week on NeurologyLive® — April 10, 2023
Remternetug Significantly Reduces Amyloid Plaque, Phase 3 INTUNE Study Accelerated, Pitolisant Approved for Pediatric Narcolepsy by EMA
Neurology News Network for the week ending April 8, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — April 7, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 7, 2023.
This Week on NeurologyLive® — April 3, 2023
Lecanemab Adds Quality-Adjusted Life Years, FDA to Hold AdComm Meeting Over NurOwn, SYMBYX Neuro Improves PD Symptoms
Neurology News Network for the week ending April 1, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — March 31, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 31, 2023.
This Week on NeurologyLive® — March 27, 2023
NeurologyLive® Friday 5 — March 24, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 24, 2023.
This Week on NeurologyLive® — March 20, 2023
Cognitive and Functional Differences in Parkinson, FDA Lifts Hold on IkT-148009, Solanezumab Shows No Impact on Cognitive Decline
Neurology News Network for the week ending March 18, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — March 17, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 17, 2023.
This Week on NeurologyLive® — March 13, 2023
Efgartigimod Improves HR-Related Quality of Life, Traditional Approval for Lecanemab Pending, Satrlizumab Benefits NMOSD After Switching
Neurology News Network for the week ending March 11, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — March 10, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 10, 2023.
This Week on NeurologyLive® — March 6, 2023
Gene Therapy ST-920 Shows Benefit in Fabry, Intermittent Calorie Restriction in Multiple Sclerosis, High Economic Burden Identified in NMOSD
Neurology News Network for the week ending March 4, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — March 3, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 3, 2023.
This Week on NeurologyLive® — February 27, 2023
Sodium Oxybate Alters Sleep Structure, FDA Approves Deutetrabenazine, Associations of Stroke Decreased With Age
Neurology News Network for the week ending February 26, 2022. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — February 24, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 24, 2023.
This Week on NeurologyLive® — February 20, 2023
CNM-Au8 Impacts Neuronal Structural Integrity, Mobile Stroke Units and Direct Transfer to Angiography, Cognitive Impairments Higher in RBD Before Parkinson Disease
Neurology News Network for the week ending February 18, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — February 17, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 17, 2023.
This Week on NeurologyLive® — February 13, 2023
PHOENIX Study Meets Enrollment, Atogepant and Ubrogepant Safe, ABATE Trial Highlights Targeted Response of Alzheimer Vaccine
Neurology News Network for the week ending February 11, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — February 10, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 10, 2023.